Wnt pathway is involved in 5-FU drug resistance of colorectal cancer cells | Experimental & Molecular Medicine
Enhanced anti-colon cancer efficacy of 5-fluorouracil by epigallocatechin-3- gallate co-loaded in wheat germ agglutinin-conjugated nanoparticles - ScienceDirect
5‐Fluorouracil efficacy requires anti‐tumor immunity triggered by cancer‐cell‐intrinsic STING | The EMBO Journal
DNA Mismatch Repair and 5-FU: What's the Connection? | Fight Colorectal Cancer
Biomolecules | Free Full-Text | Antrodia cinnamomea Enhances Chemo-Sensitivity of 5-FU and Suppresses Colon Tumorigenesis and Cancer Stemness via Up-Regulation of Tumor Suppressor miR-142-3p
Hypoxic stress induces 5-FU chemoresistance in colon cancer cells. (A)... | Download Scientific Diagram
Levamisole and Fluorouracil for Adjuvant Therapy of Resected Colon Carcinoma | NEJM
Overcoming acquired drug resistance in colorectal cancer cells by targeted delivery of 5-FU with EGF grafted hollow mesoporous silica nanoparticles - Nanoscale (RSC Publishing)
miR-203 enhances chemosensitivity to 5-fluorouracil by targeting thymidylate synthase in colorectal cancer
A systematic review of the therapeutic effects of resveratrol in combination with 5-fluorouracil during colorectal cancer treatment: with a special focus on the oxidant, apoptotic, and anti-inflammatory activities | Cancer Cell International
Curcumin Chemosensitizes 5-Fluorouracil Resistant MMR-Deficient Human Colon Cancer Cells in High Density Cultures | PLOS ONE
Cancers | Free Full-Text | 5-Fluorouracil as a Tumor-Treating Field-Sensitizer in Colon Cancer Therapy
In vitro combinatorial anticancer effects of 5-fluorouracil and curcumin loaded N,O-carboxymethyl chitosan nanoparticles toward colon cancer and in vivo pharmacokinetic studies - ScienceDirect
Over-expression of EGFR regulated by RARA contributes to 5-FU resistance in colon cancer - Figure f4 | Aging
Targeting EGFR sensitizes 5-Fu-resistant colon cancer cells through modification of the lncRNA-FGD5-AS1-miR-330-3p-Hexokinase 2 axis: Molecular Therapy - Oncolytics
5-FU promotes stemness of colorectal cancer via p53-mediated WNT/β-catenin pathway activation | Nature Communications
Frontiers | 5-Fluorouracil: A Narrative Review on the Role of Regulatory Mechanisms in Driving Resistance to This Chemotherapeutic Agent
Oxaliplatin and 5-FU/LV:The New Standard Treatment of Advanced Colorectal Cancer - CancerConnect
5-FU promotes stemness of colorectal cancer via p53-mediated WNT/β-catenin pathway activation | Nature Communications
5-FU Chemotherapy Drug To Treat Colon Cancer | Onco.com
5-FU promotes stemness of colorectal cancer via p53-mediated WNT/β-catenin pathway activation | Nature Communications
5-Fluorouracil (5-FU)-resistant colon cancer cells acquire resistance... | Download Scientific Diagram
5-Fluorouracil (5-FU) resistance and the new strategy to enhance the sensitivity against cancer: Implication of DNA repair inhibition - ScienceDirect
Over-expression of EGFR regulated by RARA contributes to 5-FU resistance in colon cancer - Figure f5 | Aging
Annexin A1 is involved in resistance to 5-FU in colon cancer cells
